Immediate support is noted around 0.6267, while upside resistance clusters near 0.6289 and 0.6290 and extends to 0.6292.

ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses positron emission tomography (PET) to evaluate olaratumab, a monoclonal antibody, as a therapeutic radiopharmaceutical ...

(ARTMS), a global leader in radioisotope production technologies, is pleased to announce that the drug master file (DMF) 1 ...

The AUD/USD pair turns sideways around 0.6250 in Tuesday’s European session. The Aussie pair flattens after the Reserve Bank ...

The huge fund intends to vote to keep Rio Tinto’s dual-listed structure, despite other shareholders supporting a bid to ...

Mergers & Aquisitions Call March 26, 2025 6:30 PM ETCompany ParticipantsNeil Rossy - President and CEOPatrick Bui ...

CAMBRIDGE, MA / ACCESS Newswire / March 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Australian Therapeutic Goods Administration (TGA) has granted approval for mRESVIA® (mRNA-1345), ...

An update from Armada Metals Ltd. ( ($AU:RLL) ) is now available. Rapid Lithium Limited has released its annual financial statements for the year ...

Detailed price information for Temas Resources Corp (TMAS-CN) from The Globe and Mail including charting and trades.

United States Centers for Medicare and Medicaid Services (CMS) Mandates Ryoncil® Coverage ...

Net flows into Australian exchange-traded funds tracking domestic equities are on track for their best quarter ever as ...

Charles Schwab Investment Management Inc. raised its holdings in SmartFinancial, Inc. (NASDAQ:SMBK – Free Report) by 1.3% in ...